IMMUNE, DERMAL AND INFECTIOUS DISEASES
For information about partnering with the NIOSH Immune, Dermal & Infectious Diseases Program, contact the Immune, Dermal & Infectious Diseases Program Coordinator . For general information about partnerships with NIOSH, contact the NIOSH Office of Research and Technology Transfer .
Dr. James Taylor
Head, Section of Industrial Dermatology
Department of Dermatology
The Cleveland Clinic
9500 Euclid Avenue
Cleveland, OH 44195
(216) 445-6365 (Fax)
Dr. Taylor has been an active member of the American Contact Dermatitis Society (ACDS). The Committee may benefit the most from Dr. Taylor’s involvement if he joins the Committee as a representative of ACDS
Dr. Ben Hayes
The Vanderbilt Clinic
1301 22nd Avenue South
Nashville, TN 37232
(615) 419-1526 (Cell)
(615) 844-3334 (Home)
Dr. Hayes is a Resident of the Division of Dermatology, Department of Medicine, Vanderbilt University and a staff member of the Vanderbilt Clinic. The research and interests of Dr. Hayes in the dermal area include general dermatology and dermatotoxicology, particularly in the evaluation of dermal penetration of allergens and the diagnosis and treatment of allergic contact dermatitis.
Dori Germolec, Ph.D.
Environmental Immunology Group
Laboratory of Molecular Toxicology
Division of Intramural Research
National Institute of Environmental Health Sciences
NIH P.O. Box 12233 (MD C1-03) Research
(919) 541-0870 (Fax)
Dr. Germolec is the leader of the Environmental Immunology Group (EIG), Laboratory of Molecular Toxicology of NIEHS. Her dermal research experience and interests include the identification of immunological responses involved in skin sensitization as a result of occupational exposure to chemical substances of industrial applications. The EIG under her leadership also conducts research to investigate the association of environmental factors with these immune responses.
G. Frank Gerberick, Ph.D.
Procter & Gamble Company
Miami Valley Laboratories
P.O. Box 538707
Cincinnati, OH 45253-8707
(513) 627-0400 (Fax)
Dr. Gerberick has conducted extensive research focusing on the development of methods for determining skin sensitization potentials of chemical substances, including the murine Local Lymph Node Assay (LLNA), and the evaluation of associated health risks. Nominated by Dr. Gerberick, the LLNA was scientifically reviewed by the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and recommended for regulatory acceptance by the U.S. agencies as a standard assay for evaluating allergenic potentials of chemicals.
Jennifer A. Sahmel, MPH, CIH, CSP
Occupational Health Manager
National Park Service - Intermountain Region
12795 W. Alameda Pkwy
P.O. Box 25287
Denver, CO 80225-0287
(303) 969-2536 (Fax)
Jennifer Sahmel is the chair of the Dermal Subcommittee, Exposure Assessment Strategies Committee, American Industrial Hygiene Association (AIHA Dermal Subcommittee) and the vice chair of the Exposure Assessment Strategies Committee. Ms. Sahmel is a Certified Industrial Hygienist. Under her leadership the AIHA Dermal Subcommittee in recent years has focused on developing strategies of dermal exposure assessment, management, and control. Ms. Sahmel will chair the 2007 Occupational and Environmental Exposures of Skin to Chemicals.
Stakeholders and Customers
The NIOSH Program for Immune, Dermal, & Infectious Diseases collaborates and works closely with a broad spectrum of the Immune, Dermal, & Infectious Diseases community. The stakeholder and customer list is extensive, including industry, labor, academia, government agencies, non-governmental organizations, and professional organizations both domestic and international. These organizations may be research partners, as described in the previous section. They may also be users of our technology and scientific findings, peer reviewers, recipients of research grants and contracts, or sources of equipment, technology, or knowledge for advancing research in the Immune, Dermal, & Infectious Diseases community.
The NIOSH-Stakeholder Joint Workgroup on Skin Notations is part of the of the program’s aims to help evaluate scientific data for assigning skin notations through collaboration between NIOSH scientists and stakeholders with expertise in occupational skin exposures and diseases.
The regular members include representatives from NIOSH, Procter & Gamble Company, National Institute of Environmental Health Sciences, Vanderbilt University, National Park Service - Intermountain Region, and the Cleveland Clinic.
The collaborative efforts intend to: 1) review and evaluate scientific literature identifying the chemical substances of potential toxicity to the skin or systemic effects by route of skin absorption and the relevant occupational exposures; 2) provide input to the assignment of chemical-specific NIOSH skin notations and the development of scientific documentation based on review findings; 3) explore research needed to fill the knowledge gaps when currently available scientific data are determined to be insufficient to support a decision on notations. To achieve these objectives, the workgroup shall meet regularly, approximately three to four times a year, to conduct the review for pre-determined chemical substances and to develop recommendations. The workgroup shall first focus the effort on chemical substances of priority as determined from data indicative of severe health impacts resulting from skin contact or of significant workplace exposures.
- Page last reviewed: December 18, 2012
- Page last updated: December 18, 2012
- Content source: